ATM antagonizes NHEJ proteins assembly and DNA-ends synapsis at single-ended DNA double strand breaks.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
25 09 2020
Historique:
accepted: 21 08 2020
revised: 29 07 2020
received: 20 09 2019
pubmed: 6 9 2020
medline: 11 11 2020
entrez: 5 9 2020
Statut: ppublish

Résumé

Two DNA repair pathways operate at DNA double strand breaks (DSBs): non-homologous end-joining (NHEJ), that requires two adjacent DNA ends for ligation, and homologous recombination (HR), that resects one DNA strand for invasion of a homologous duplex. Faithful repair of replicative single-ended DSBs (seDSBs) is mediated by HR, due to the lack of a second DNA end for end-joining. ATM stimulates resection at such breaks through multiple mechanisms including CtIP phosphorylation, which also promotes removal of the DNA-ends sensor and NHEJ protein Ku. Here, using a new method for imaging the recruitment of the Ku partner DNA-PKcs at DSBs, we uncover an unanticipated role of ATM in removing DNA-PKcs from seDSBs in human cells. Phosphorylation of DNA-PKcs on the ABCDE cluster is necessary not only for DNA-PKcs clearance but also for the subsequent MRE11/CtIP-dependent release of Ku from these breaks. We propose that at seDSBs, ATM activity is necessary for the release of both Ku and DNA-PKcs components of the NHEJ apparatus, and thereby prevents subsequent aberrant interactions between seDSBs accompanied by DNA-PKcs autophosphorylation and detrimental commitment to Lig4-dependent end-joining.

Identifiants

pubmed: 32890395
pii: 5901963
doi: 10.1093/nar/gkaa723
pmc: PMC7515714
doi:

Substances chimiques

DNA, Single-Stranded 0
LIG4 protein, human 0
MRE11 protein, human 0
Topoisomerase I Inhibitors 0
ATM protein, human EC 2.7.11.1
Ataxia Telangiectasia Mutated Proteins EC 2.7.11.1
DNA-Activated Protein Kinase EC 2.7.11.1
PRKDC protein, human EC 2.7.11.1
MRE11 Homologue Protein EC 3.1.-
XRCC5 protein, human EC 3.6.4.12
Ku Autoantigen EC 4.2.99.-
DNA Ligase ATP EC 6.5.1.1
Camptothecin XT3Z54Z28A

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9710-9723

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Prog Biophys Mol Biol. 2015 Mar;117(2-3):194-205
pubmed: 25550082
Mutat Res. 2017 Oct;803-805:51-55
pubmed: 28781144
Bioorg Med Chem Lett. 2004 Dec 20;14(24):6083-7
pubmed: 15546735
J Biol Chem. 2013 Mar 8;288(10):7086-95
pubmed: 23355489
Nat Commun. 2017 Dec 7;8(1):1982
pubmed: 29215009
Nature. 2015 Dec 17;528(7582):422-6
pubmed: 26649820
J Biol Chem. 1999 Jul 9;274(28):20034-9
pubmed: 10391954
Mol Cell Biol. 2003 Aug;23(16):5836-48
pubmed: 12897153
J Biol Chem. 2018 Nov 2;293(44):17061-17069
pubmed: 30224356
J Biol Chem. 2004 Sep 3;279(36):37343-8
pubmed: 15218034
Mol Cell. 2017 Sep 7;67(5):891-898.e4
pubmed: 28867292
J Biol Chem. 2013 Dec 27;288(52):37112-25
pubmed: 24220101
J Immunol. 2016 Apr 1;196(7):3032-42
pubmed: 26921311
Mol Cancer Ther. 2014 Feb;13(2):433-43
pubmed: 24356813
J Cell Biol. 2007 Apr 23;177(2):219-29
pubmed: 17438073
Mol Cell. 1998 Oct;2(4):477-84
pubmed: 9809069
DNA Repair (Amst). 2003 Apr 2;2(4):363-74
pubmed: 12606118
J Virol. 2003 Aug;77(16):8957-61
pubmed: 12885912
J Cell Biol. 2013 Aug 5;202(3):579-95
pubmed: 23897892
Cancer Res. 2004 Dec 15;64(24):9152-9
pubmed: 15604286
Oncotarget. 2017 Jul 4;8(27):43733-43751
pubmed: 28415827
Br J Radiol. 2014 Mar;87(1035):20130685
pubmed: 24363387
Mol Cell Biol. 2007 May;27(10):3881-90
pubmed: 17353268
Sci Adv. 2020 Jan 08;6(2):eaay0922
pubmed: 31934630
Semin Cancer Biol. 2016 Jun;37-38:51-64
pubmed: 27016036
PLoS One. 2010 Nov 30;5(11):e14142
pubmed: 21152442
Nucleic Acids Res. 2003 Dec 15;31(24):7238-46
pubmed: 14654699
Mol Cell. 2016 Jan 7;61(1):15-26
pubmed: 26687679
Genes Dev. 2017 Dec 1;31(23-24):2331-2336
pubmed: 29321177
Nat Commun. 2016 Sep 19;7:12889
pubmed: 27641979
Nature. 2001 Aug 9;412(6847):607-14
pubmed: 11493912
Nature. 2011 Oct 16;479(7372):241-4
pubmed: 22002605
Nat Commun. 2019 Jan 8;10(1):87
pubmed: 30622252
Cell Rep. 2013 Jun 27;3(6):2033-45
pubmed: 23770241
PLoS One. 2011;6(8):e23517
pubmed: 21858151
Nat Rev Mol Cell Biol. 2017 Aug;18(8):495-506
pubmed: 28512351
J Biol Chem. 2010 Jan 8;285(2):1414-23
pubmed: 19893054
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Mol Cell. 2016 Dec 1;64(5):940-950
pubmed: 27889449
J Biol Chem. 2010 May 14;285(20):15201-8
pubmed: 20304914
PLoS One. 2013 Nov 07;8(11):e79202
pubmed: 24244448
Mol Cell. 2017 Jan 5;65(1):91-104
pubmed: 27939942
Nucleic Acids Res. 2019 Oct 10;47(18):9467-9479
pubmed: 31396623
J Clin Invest. 2013 Jul;123(7):2969-80
pubmed: 23722905
Front Genet. 2018 Sep 12;9:390
pubmed: 30258457
Nucleic Acids Res. 2016 Feb 18;44(3):1161-78
pubmed: 26578593
Genes Dev. 2017 Dec 1;31(23-24):2325-2330
pubmed: 29321179
Mol Cell. 2019 Jul 11;75(1):145-153.e5
pubmed: 31153714
DNA Repair (Amst). 2012 Mar 1;11(3):310-6
pubmed: 22265216
Prog Biophys Mol Biol. 2019 Oct;147:62-76
pubmed: 30851288
Mol Cell. 2015 Apr 2;58(1):172-85
pubmed: 25818648
Elife. 2017 May 13;6:
pubmed: 28500754
J Cell Biol. 2013 Aug 5;202(3):421-9
pubmed: 23897887
PLoS Genet. 2011 Sep;7(9):e1002271
pubmed: 21931565
Curr Opin Struct Biol. 2019 Apr;55:154-160
pubmed: 31125797
Nat Struct Mol Biol. 2018 Jun;25(6):482-487
pubmed: 29786079
J Biol Chem. 2007 Mar 2;282(9):6582-7
pubmed: 17189255
Mol Cell Biol. 2014 Jun;34(12):2162-75
pubmed: 24687855
Bioessays. 2017 Mar;39(3):
pubmed: 28133776
J Biol Chem. 2018 Jul 6;293(27):10524-10535
pubmed: 29599286
Genes Cells. 2006 Mar;11(3):237-46
pubmed: 16483312
EMBO J. 2010 Oct 6;29(19):3358-69
pubmed: 20729809
Mol Cell Biol. 2005 Dec;25(24):10842-52
pubmed: 16314509
J Biol Chem. 1996 Jun 14;271(24):14405-11
pubmed: 8662903
Mol Cell Biol. 2007 Mar;27(5):1581-91
pubmed: 17158925
Nucleic Acids Res. 2012 Feb;40(4):1684-94
pubmed: 22228831
Nature. 2008 Nov 27;456(7221):529-33
pubmed: 18931658
Mol Cell. 2010 Oct 22;40(2):179-204
pubmed: 20965415
EMBO J. 2002 Jun 17;21(12):3192-200
pubmed: 12065431
DNA Repair (Amst). 2018 Nov;71:158-163
pubmed: 30195640
J Biol Chem. 2005 Apr 15;280(15):14709-15
pubmed: 15677476
Mol Cell. 2016 Mar 17;61(6):850-8
pubmed: 26990988
PLoS Genet. 2009 Nov;5(11):e1000722
pubmed: 19911044
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
J Biol Chem. 2018 Jul 6;293(27):10502-10511
pubmed: 29414795
J Immunol. 2000 Feb 1;164(3):1416-24
pubmed: 10640757
Nucleic Acids Res. 2011 Dec;39(22):9605-19
pubmed: 21880593
Mol Cell Biol. 2015 Sep 1;35(17):3017-28
pubmed: 26100018
Mol Cell Biol. 2011 Nov;31(21):4379-89
pubmed: 21876003
DNA Repair (Amst). 2019 Jan;73:7-16
pubmed: 30409670
Nucleic Acids Res. 2011 Jul;39(13):5757-67
pubmed: 21450809
DNA Repair (Amst). 2020 Oct;94:102925
pubmed: 32674014
J Cell Biol. 2013 Jan 21;200(2):173-86
pubmed: 23337116
EMBO Rep. 2008 Aug;9(8):810-8
pubmed: 18600234
Nat Rev Mol Cell Biol. 2016 Nov;17(11):703-721
pubmed: 27649880
Nucleic Acids Res. 1999 Dec 15;27(24):4679-86
pubmed: 10572166
DNA Repair (Amst). 2018 Nov;71:164-171
pubmed: 30177438
Nat Rev Mol Cell Biol. 2019 Nov;20(11):698-714
pubmed: 31263220
J Biol Chem. 2018 Jul 6;293(27):10512-10523
pubmed: 29247009
Nucleic Acids Res. 2004 Aug 16;32(14):4351-7
pubmed: 15314205
Cell Rep. 2019 Aug 6;28(6):1564-1573.e3
pubmed: 31390569
J Proteome Res. 2019 Mar 1;18(3):1064-1077
pubmed: 30585729

Auteurs

Sébastien Britton (S)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Equipe Labellisée Ligue contre le Cancer 2018, Toulouse, France.

Pauline Chanut (P)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Equipe Labellisée Ligue contre le Cancer 2018, Toulouse, France.

Christine Delteil (C)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Equipe Labellisée Ligue contre le Cancer 2018, Toulouse, France.

Nadia Barboule (N)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Equipe Labellisée Ligue contre le Cancer 2018, Toulouse, France.

Philippe Frit (P)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Equipe Labellisée Ligue contre le Cancer 2018, Toulouse, France.

Patrick Calsou (P)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Equipe Labellisée Ligue contre le Cancer 2018, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH